Subscribe to RSS
Diagnostic value of FDG-PET/CT in the diagnostic work-up of inflammation of unknown originWertigkeit der PET/CT im Rahmen der Entzündungsherddiagnostik mit F-18-FDG
Introduction The present study aims to evaluate the clinical diagnostic value of FDG-PET/CT in patients with inflammation of unknown origin. Material and methods We retrospectively analyzed data of 130 patients who presented general inflammatory symptoms and/or elevated level of CRP and underwent FDG-PET/CT for the purpose of identifying unknown foci of inflammation. The accuracy of PET/CT findings was assessed against the standard of eventual clinical diagnosis e.g. results of pathology, microbiology or other imaging methods. Results In 99/130 patients (76 %) a final diagnosis was established, FDG-PET/CT showed a sensitivity and specificity of each 93 %. A decreased pseudocholinesterase is associated with a higher SUVmax value and with a higher CRP value whereas no significant relationship was found between elevated CRP values and the SUVmax, although higher CRP values are associated significantly with a true positive PET/CT result. Conclusion FDG-PET/CT is a highly sensitive, specific and accurate method for the detection of foci of inflammation of unknown origin. The combination of decreased pseudocholinesterase and increased CRP levels may be a useful tool to select patients for FDG PET/CT.
Received: 12 October 2022
Accepted: 08 November 2022
Article published online:
09 January 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Mulders-Manders C, Kouijzer I, Janssen M. et al. Optimal use of 18F-FDG-PET/CT in patients with fever or inflammation of unknown origin. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019; DOI: 10.23736/S1824-4785.19.03129-7. (PMID: 31271266)
- 2 Fusco F, Pisapia R, Nardiello S. et al. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. BMC Infectious Diseases 2019; 19: 653 DOI: 10.1186/s12879-019-4285-8. (PMID: 31331269)
- 3 Balink H, Collins J, Bruyn G. et al. F-18-FDG PET/CT in the diagnosis of fever of unknown origin. Clinical Nuclear Medicine 2009; 34 (12) 862-868 DOI: 10.1097/RLU.0b013e3181becfb1.
- 4 Bouter C, Braune I, Meller B. et al. 18F-FDG-PET/CT in unexplained elevated inflammatory markers. Joining entities. Nuklearmedizin. Nuclear medicine 2016; 55 (06) 242-249 DOI: 10.3413/Nukmed-0798-16-02. (PMID: 27617327)
- 5 Balink H, Bennink R, Veeger N. et al. Diagnostic utility of 18F-FDG PET/CT in inflammation of unknown origin. Clinical Nuclear Medicine 2014; 39 (05) 419-425 DOI: 10.1097/RLU.0000000000000423. (PMID: 24662652)
- 6 Vanderschueren S, Del Biondo E, Ruttens D. et al. Inflammation of unknown origin versus fever of unknown origin: two of a kind. European journal of internal medicine 2009; 20 (04) 415-418 DOI: 10.1016/j.ejim.2009.01.002. (PMID: 19524186)
- 7 Balink H, Verbene H, Bennink R. et al. A Rationale for the Use of F18-FDG PET/CT in Fever and Inflammation of unknown origin. International Journal of Molecular Imaging 2012; DOI: 10.1155/2012/165080.
- 8 Kouijzer I, Mulders-Manders C, Bleeker-Rovers C. et al. Fever of Unknown Origin: the Value of FDG-PET/CT. Seminars in Nuclear Medicine 2018; 48 (02) 100-107 DOI: 10.1053/j.semnuclmed.2017.11.004.
- 9 Hubbard R, O'Mahony M, Calver B. et al. Plasma esterases and inflammation in ageing and frailty. European journal of clinical pharmacology 2008; 64 (09) 895-900 DOI: 10.1007/s00228-008-0499-1. (PMID: 18506436)